Use of mesalazine slow release suppositories 1 g three times per week to maintain remission of ulcerative proctitis: a randomised double blind placebo controlled multicentre study.
| Author | |
|---|---|
| Abstract |
:
Daily administration of rectal formulations of mesalazine is effective in preventing relapse of ulcerative proctitis. Maintenance of remission with lower doses would be an advantage. |
| Year of Publication |
:
1998
|
| Journal |
:
Gut
|
| Volume |
:
42
|
| Issue |
:
2
|
| Number of Pages |
:
195-9
|
| ISSN Number |
:
0017-5749
|
| URL |
:
https://gut.bmj.com/lookup/pmidlookup?view=long&pmid=9536943
|
| DOI |
:
10.1136/gut.42.2.195
|
| Short Title |
:
Gut
|
| Download citation |
